Bosco Labs

Tools › Questions › ClinicalTrials.gov API

Which obesity trials is Novo Nordisk running right now?

Answered byClinicalTrials.gov API: trial search & NCT dossier
Price$0.004 per trial (HTTP API)
StatusOn the HTTP API

ClinicalTrials.gov lists Novo Nordisk as lead sponsor of obesity trials that are recruiting, about to recruit or running. Each row has the NCT number, phase, status, interventions, enrollment, start and estimated primary completion dates, countries and site count, with a link to the trial.

Tool input

{
  "sponsor": "Novo Nordisk",
  "condition": "obesity",
  "status": [
    "RECRUITING",
    "NOT_YET_RECRUITING",
    "ACTIVE_NOT_RECRUITING"
  ],
  "maxResults": 20
}

Ask it from an AI agent (MCP)

Add the Apify MCP server with this tool to your MCP client (Claude, Cursor, VS Code, ...); it signs you in with OAuth or Authorization: Bearer <APIFY_TOKEN>. It works once the Actor is listed on the Apify Store; until then use the HTTP API or the remote MCP server at https://api.boscolabs.dev/mcp.

https://mcp.apify.com?tools=bosco_labs/clinical-trials

Then ask:

Use the bosco_labs/clinical-trials tool to answer: Which obesity trials is Novo Nordisk running right now?

Call the Apify API

Runs the Actor and returns the rows in one request, billed to your Apify account ($0.004 per trial (HTTP API)). It works once the Actor is listed on the Apify Store; until then use the HTTP API or the remote MCP server at https://api.boscolabs.dev/mcp.

curl https://api.apify.com/v2/acts/bosco_labs~clinical-trials/run-sync-get-dataset-items \
  -H "Authorization: Bearer $APIFY_TOKEN" \
  -H "Content-Type: application/json" \
  -d '{"sponsor": "Novo Nordisk", "condition": "obesity", "status": ["RECRUITING", "NOT_YET_RECRUITING", "ACTIVE_NOT_RECRUITING"], "maxResults": 20}'

Call the Bosco Labs HTTP API

Bosco Labs HTTP API (beta): same input and rows, $0.004 per trial from prepaid credits. Get a key with a $0.50 free trial, or send the same call without a key and pay per call in USDC via x402 (no account).

curl https://api.boscolabs.dev/v1/clinical-trials \
  -H "Authorization: Bearer $BOSCO_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"sponsor": "Novo Nordisk", "condition": "obesity", "status": ["RECRUITING", "NOT_YET_RECRUITING", "ACTIVE_NOT_RECRUITING"], "maxResults": 20}'

Example output

Snapshot taken 2026-11-06, source links in each row. First 1 of 5 rows (snapshot runs stop at 5 rows); long values shortened.

[
  {
    "nct_id": "NCT07411560",
    "title": "A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese",
    "acronym": null,
    "status": "RECRUITING",
    "phases": [
      "PHASE1"
    ],
    "study_type": "INTERVENTIONAL",
    "conditions": [
      "Overweight",
      "Obese"
    ],
    "interventions": [
      {
        "type": "DRUG",
        "name": "Glucose-dependent Insulinotropic Polypeptide (GIP)"
      },
      {
        "type": "DRUG",
        "name": "Cagrilintide"
      },
      {
        "type": "DRUG",
        "name": "Placebo GIP"
      }
    ],
    "sponsor": "Novo Nordisk A/S",
    "sponsor_class": "INDUSTRY",
    "collaborators": [],
    "enrollment_count": 100,
    "enrollment_type": "ESTIMATED",
    "start_date": "2026-02-09",
    "start_date_type": "ACTUAL",
    "primary_completion_date": "2027-01-26",
    "primary_completion_date_type": "ESTIMATED",
    "completion_date": "2027-01-26",
    "completion_date_type": "ESTIMATED",
    "last_update_posted": "2026-04-13",
    "countries": [
      "United Kingdom"
    ],
    "site_count": 1,
    "primary_outcomes": [
      {
        "measure": "Number of Treatment Emergent Adverse Events (TEAEs) nausea, vomiting and diarrhoea",
        "time_frame": "From first investigational medicinal products (IMP) administration (visit 2, day 1 or visit 9, day 74) to the end of treatment visit (Visit 2, day 16 or Visi..."
      }
    ],
    "primary_outcomes_total": 1,
    "has_results": false,
    "results_first_posted": null,
    "brief_summary": "This trial is being done to look at the safety and effect of combining cagrilintide and NNC0480-0389 in people living with overweight and obesity compared to...",
    "eligibility": null,
    "arms": null,
    "secondary_outcomes": null,
    "sites": null,
    "source_url": "https://clinicaltrials.gov/study/NCT07411560",
    "...": "4 more fields"
  }
]
Call it on the HTTP API →All fields and limits

More questions for this tool

All questions